Durham, NC, United States of America

Om Parkash Dhingra

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Smithkline Beecham Corporation. Active years: 2006.


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Om Parkash Dhingra: Innovator in Crystal Form Screening Technology

Introduction

Om Parkash Dhingra is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of drug formulation through his innovative patent. His work focuses on enhancing the efficiency of crystal form screening, which is crucial in pharmaceutical development.

Latest Patents

Dhingra holds a patent for a "High throughput crystal form screening workstation and method of use." This invention features a filtration assembly that operates in conjunction with a crystal form screening workstation, enabling automated screening of crystal forms. The assembly includes first and second valves, each equipped with internal passages and multiple ports. A filter line is strategically placed between the valves, allowing for the filtration of drug-containing suspensions. The filter medium is designed to function effectively under both positive and negative pressure conditions, showcasing its versatility in various operational environments.

Career Highlights

Throughout his career, Dhingra has worked with prominent companies such as SmithKline Beecham Corporation and Monsanto Company. His experience in these organizations has contributed to his expertise in pharmaceutical technologies and innovations.

Collaborations

Some of his notable coworkers include David Leroy Carlton and David Igo. Their collaboration has likely fostered a productive environment for innovation and development in their respective fields.

Conclusion

Om Parkash Dhingra's contributions to crystal form screening technology exemplify the importance of innovation in the pharmaceutical industry. His patent reflects a commitment to improving drug formulation processes, which can lead to more effective therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…